Groowe Groowe / Newsroom / KRYS
⏱ News is delayed by 15 minutes. Sign in for real-time access. Sign in

KRYS News

Krystal Biotech, Inc. Common Stock

Krystal Biotech to Report Second Quarter 2026 Financial Results on August 3, 2026

globenewswire.com
KRYS

Form 8-K

sec.gov
KRYS

Krystal Biotech Set to Join S&P MidCap 400; Tutor Perini and V2X to Join S&P SmallCap 600

prnewswire.com
SPGI KRYS TPC VVX

Corbus Pharmaceuticals Announces the Appointment of Nishant Saxena as Chief Business Officer and Schedules a Pre-2026 ASCO CRB-701 Data Conference Call

globenewswire.com
CRBP KRYS

Form 8-K

sec.gov
KRYS

Krystal Biotech Announces United Kingdom MHRA Approval of VYJUVEKĀ® for the Treatment of Dystrophic Epidermolysis Bullosa

globenewswire.com
KRYS

Krystal Biotech to Present at BofA Securities 2026 Health Care Conference

globenewswire.com
KRYS

Form 8-K

sec.gov
KRYS

Krystal Biotech Announces First Quarter 2026 Financial and Operating Results

globenewswire.com
KRYS

Krystal Biotech to Present at Upcoming Scientific Conferences

globenewswire.com
KRYS